1
|
Wu YX, Zhang YD, Li N, Wu DD, Li QM, Chen YZ, Zhang GC, Yang J. Inhibitory effect and mechanism of action of juniper essential oil on gray mold in cherry tomatoes. Front Microbiol 2022; 13:1000526. [PMID: 36212845 PMCID: PMC9537556 DOI: 10.3389/fmicb.2022.1000526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2022] [Accepted: 08/31/2022] [Indexed: 11/13/2022] Open
Abstract
Juniper essential oil (JEO), which is mostly known as an immune system booster and effective detoxifier, has substantial antimicrobial activity. A comparison of the inhibitory effects of three plant essential oils from juniper (Juniperus rigida), cedarwood (Juniperus virginiana), and cypress (Crupressus sempervirens) on four plant pathogenic fungi indicated that JEO was the most effective at inhibiting the growth of gray mold (Botrytis cinerea). Additional studies were subsequently conducted to explore the in vivo and in vitro antifungal activity and possible mechanism of JEO against B. cinerea. The results show that JEO inhibited the germination of spores and mycelial growth of B. cinerea in a concentration-dependent manner and exhibited strong inhibition when its concentration exceeded 10 μL/mL. JEO also significantly inhibited the incidence of disease and diameters of gray mold lesions on cherry tomato fruit (Solanum lycopersicum). After 12 h of treatment with JEO, the extracellular conductivity, and the contents of soluble protein, malondialdehyde, and hydrogen peroxide were 3.1, 1.2, 7.2, and 4.7 folds higher than those of the control group, respectively (P < 0.05), which indicated that JEO can damage membranes. Scanning electron microscopy observations revealed that JEO affected the morphology of mycelia, causing them to shrivel, twist and distort. Furthermore, JEO significantly improved the activities of the antioxidant-related enzymes superoxide dismutase and catalase but reduced the pathogenicity-related enzymes polygalacturonase (PG), pectin lyase and endoglucanase of B. cinerea (P < 0.05). In particular, PG was reduced by 93% after treatment with JEO for 12 h. Moreover, the 18 constituents of JEO were identified by gas chromatography/mass spectrometry (GC-MS) analysis, mainly limonene (15.17%), γ-terpinene (8.3%), β-myrcene (4.56%), terpinen-4-ol (24.26%), linalool (8.73%), α-terpineol (1.03%), o-cymene (8.35%) and other substances with antimicrobial activity. Therefore, JEO can be an effective alternative to prevent and control gray mold on cherry tomato fruit.
Collapse
Affiliation(s)
- Yu-Xuan Wu
- Heilongjiang Province Key Laboratory of Forest Protection, School of Forest, Northeast Forestry University, Harbin, China
| | - Yun-Di Zhang
- Heilongjiang Province Key Laboratory of Forest Protection, School of Forest, Northeast Forestry University, Harbin, China
| | - Na Li
- Heilongjiang Province Key Laboratory of Forest Protection, School of Forest, Northeast Forestry University, Harbin, China
| | - De-Dong Wu
- Heilongjiang Province Key Laboratory of Forest Protection, School of Forest, Northeast Forestry University, Harbin, China
| | - Qi-Meng Li
- Heilongjiang Province Key Laboratory of Forest Protection, School of Forest, Northeast Forestry University, Harbin, China
| | - Yun-Ze Chen
- Heilongjiang Province Key Laboratory of Forest Protection, School of Forest, Northeast Forestry University, Harbin, China
- School of Biological Sciences, Guizhou Education University, Guiyang, China
| | - Guo-Cai Zhang
- Heilongjiang Province Key Laboratory of Forest Protection, School of Forest, Northeast Forestry University, Harbin, China
- *Correspondence: Guo-Cai Zhang,
| | - Jing Yang
- Heilongjiang Province Key Laboratory of Forest Protection, School of Forest, Northeast Forestry University, Harbin, China
- College of Forestry, Guizhou University, Guiyang, China
- Jing Yang,
| |
Collapse
|
2
|
Ebrahim-Habibi A, Kashani-Amin E, Larijani B. Modeling and simulation in medical sciences: an overview of specific applications based on research experience in EMRI (Endocrinology and Metabolism Research Institute of Tehran University of Medical Sciences). J Diabetes Metab Disord 2021:1-7. [PMID: 33500880 PMCID: PMC7821172 DOI: 10.1007/s40200-020-00706-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/28/2020] [Revised: 11/26/2020] [Accepted: 12/07/2020] [Indexed: 01/31/2023]
Abstract
The concomitant use of various types of models (in silico, in vitro, and in vivo) has been exemplified here within the context of biomedical researches performed in the Endocrinology and Metabolism Research Institute (EMRI) of Tehran University of Medical Sciences. Two main research aeras have been discussed: the search for new small molecules as therapeutics for diabetes and related metabolic conditions, and diseases related to protein aggregation. Due to their multidisciplinary nature, the majority of these studies have needed the collaboration of different specialties. In both cases, a brief overview of the subject is provided through literature examples, and sequential use of these methods is described.
Collapse
Affiliation(s)
- Azadeh Ebrahim-Habibi
- Biosensor Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Jalal-al-Ahmad Street, Chamran Highway, 1411713137 Tehran, Iran
| | - Elaheh Kashani-Amin
- Biosensor Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Jalal-al-Ahmad Street, Chamran Highway, 1411713137 Tehran, Iran
| | - Bagher Larijani
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
3
|
Chinisaz M, Ebrahim-Habibi A, Dehpour AR, Yaghmaei P, Parivar K, Moosavi-Movahedi AA. Structure and function of anhydride-modified forms of human insulin: In silico, in vitro and in vivo studies. Eur J Pharm Sci 2017; 96:342-350. [DOI: 10.1016/j.ejps.2016.09.030] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2016] [Revised: 09/19/2016] [Accepted: 09/21/2016] [Indexed: 01/20/2023]
|
4
|
Yaghmaei P, Azarfar K, Dezfulian M, Ebrahim-Habibi A. Silymarin effect on amyloid-β plaque accumulation and gene expression of APP in an Alzheimer's disease rat model. ACTA ACUST UNITED AC 2014; 22:24. [PMID: 24460990 PMCID: PMC3904165 DOI: 10.1186/2008-2231-22-24] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2013] [Accepted: 12/03/2013] [Indexed: 11/24/2022]
Abstract
Background The deposition of amyloid peptides is associated with Alzheimer’s disease (AD). These amyloid peptides are derived from the amyloid protein precursor (APP). Silymarin, a standardized extract of milk thistle, which is currently used in liver diseases, may be effective in the inhibition of amyloid formation. However, its effect has not been assessed on APP expression. Results In this study, first, the effect of silymarin was examined on the passive avoidance learning in a rat model of AD. This model was induced by the intracerebroventricular injection of Aβ peptide (Aβ1–42) in Wistar rats. Rats were treated with 70 and 140 mg/kgof the extract, once a day, for 4 weeks. Memory function that was evaluated in a shuttle-cage test, showed improvement upon administration of this extract. Brain amyloid plaques had also decreased upon administration of the extract. Furthermore, APP gene expression was compared in treated and untreated groups. The result showed that silymarin was able to suppress APP expression. Conclusion Our results are in accordance with the in vitro tests concerning the positive antiamyloidogenic property of the main component of silymarin, namely silibinin. We suggest that the beneficial effect of sylimarin in the AD model is related to its capacity to disaggregate amyloid plaques and to suppress APP expression. Considering the limited side effects of silymarin, this compound could be of use in AD therapy.
Collapse
Affiliation(s)
- Parichehreh Yaghmaei
- Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
| | | | | | | |
Collapse
|